Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 4 1Phase 2 1

Status

Terminated 3Withdrawn 1Unknown 1Recruiting 1

Sponsor Class

OTHER 2FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1

Conditions

Neoplasms 3Anxiety Disorders 3Pain 2Gastrointestinal Neoplasms 2Depression 2Acute Pain 2Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pain, Postoperative 1Otolaryngeal Cancer 1Mucositis 1Lymphoma, Follicular 1Head and Neck Neoplasms 1Fatigue 1Colorectal Neoplasms 1Cancer: Breakthrough Pain 1Agnosia 1

Interventions

Surveys and Questionnaires 5Ketamine 3Standard of Care 2Methods 2Early Intervention, Educational 2Yoga 1Ultraviolet Therapy 1Self-Help Groups 1Psychotherapy, Group 1Psychotherapy 1Psychiatric Rehabilitation 1Propranolol 1Practice Guidelines as Topic 1N-Methyl-3,4-methylenedioxyamphetamine 1Mindfulness-Based Stress Reduction 1Midazolam 1Melatonin 1Meditation 1Interviews as Topic 1Exercise Therapy 1Educational Status 1Cognitive Behavioral Therapy 1Caregivers 1Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Anxiety Disorders × Ketamine × Clear all
NCT06001372 2025-04-16

TREK

University of Utah

Phase EARLY_PHASE1 Terminated
2 enrolled 9 charts
Gastrointestinal

Anxiety Disorders, Depression, Gastrointestinal Neoplasms

NCT03043430 2023-04-25

Intranasal Ketamine for Anxiolysis in Pediatric Emergency Department Patients

Brooke Army Medical Center

Phase 4 Terminated
10 enrolled
LymphoidOther hematologic neoplasm

Anxiety Disorders, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01680172 2016-02-29

Oral Ketamine in the Treatment of Depression and Anxiety in Patients With Cancer

Mayo Clinic

Phase 2 Terminated
5 enrolled 6 charts

Anxiety Disorders, Depression, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡